Lp(a) as a treatment target in aortic stenosis

Growing evidence supports a role for Lp(a) in both initiation and progression of aortic valve stenosis (AVS), with potential for novel medical interventions before valve replacement is needed. This was the key message to emerge from a series of presentations on Lp(a) and AVS that included biological, Mendelian randomisation and epidemiological data linking Lp(a) to AVS.